SAT – e-Medicine

Optimal management of patients has to detect emerging symptoms in time and to administer an appropriate therapy in order to avoid decompensation and hospital admission. Telemonitoring of physiological and clinical parameters supplies valuable information to improve health care of patients.

Improving medical testing and diagnosis of diseases that currently require patients to travel to hospitals and central care settings is an important issue. The researchers at E-Medicine should specifically target the health care needs of people in remote and rural regions who may have difficulty accessing specialist health care services.

E-Medicine should be a multidisciplinary discipline with a scientific and technical vocation. The goal is to bring together the people who share the same viewpoint concerning the possibility and the necessity of the use of emerging technologies for human health. Physicians and scientists would be committed to study diseases, whether common or rare, through their research in the fields of biology, medicine, epidemiology, pharmacology and bioengineering.

E-Medicine needs and international network of researchers, health professionals and partners from the universities, industry and public health administrations. This organization should ensure that the results of the research will be applied directly to patient care. Telemedicine programs into the rural and remote communities should benefice from this project.

ICT has become one of the revolutionary disciplines changing the face of Medicine. Its role and integration in Medicine is the objective of this SAT.

Juan C. Chachques - Committee Chair

European Hospital Georges Pompidou
Paris, France

Dr. Juan C. Chachques is the Director of Cardiac Research at the Alain Carpentier Foundation, and cardiac surgeon at the HEGP. He graduated of MD at the Faculty of Medicine of Rosario, Argentine. He obtained MS and PhD at the University of Paris, France. After clinical and surgical cardiologic training in Broussais Hospital of Paris, he gained expertise in experimental and clinical procedures for the treatment of heart failure. He developed Cardiac Bioassist surgical techniques, e.g. latissimus dorsi dynamic cardiomyoplasty, dynamic aortomyoplasty, atriomyoplasty. More recently he developed cell-based and tissue engineered procedures for myocardial support and regeneration, i.e. cellular cardiomyoplasty and bioartificial myocardium. He is a clinician and surgical scientist with expertise in myocardial diseases and valve repair procedures. He pursues his research interests in the integrative electrophysiology and cellular biology, the goal is to use in-vitro and in-vivo functional electrostimulation for cardiomyogenic stem-cell conditionning in order to create a dynamic cell based cardiac support. He is the founder and president of the Cardiac Bioassist Association. His further clinical research focuses on e-medecine and in the development of clinical trials for heart failure patients, e.g. the MAGNUM Trial: Myocardial Assistance by Grafting a New Upgraded bioartificial Myocardium.